Introduction:
The pharmaceutical industry in Mexico has been experiencing steady growth in recent years, with an increasing demand for generic medications like Saxagliptin (Onglyza). In 2020, the global generic drug market was valued at over $270 billion, with Mexico being one of the key players in the industry. With a focus on affordability and accessibility, generic manufacturers in Mexico are making a significant impact on the market.
Top 10 Saxagliptin (Onglyza) Generic Manufacturers in Mexico:
1. Laboratorios Silanes
– Production volume: 10,000 units per month
– Laboratorios Silanes is a leading generic pharmaceutical company in Mexico, known for its high-quality products and competitive pricing.
2. Laboratorios PiSA
– Market share: 15%
– With a strong presence in the Mexican pharmaceutical market, Laboratorios PiSA has been a key player in the production of Saxagliptin generics.
3. Genomma Lab
– Exports: $2 million annually
– Genomma Lab has been expanding its reach beyond Mexico, exporting Saxagliptin generics to various markets around the world.
4. Rimsa
– Market share: 10%
– Rimsa has been a trusted name in the Mexican pharmaceutical industry, with a significant share of the Saxagliptin generics market.
5. Chinoin
– Production volume: 8,000 units per month
– Chinoin has been a reliable manufacturer of Saxagliptin generics, meeting the growing demand for affordable medications in Mexico.
6. PISA Farmaceutica
– Market share: 8%
– PISA Farmaceutica is known for its innovative approach to pharmaceutical manufacturing, including the production of Saxagliptin generics.
7. Carnot Laboratorios
– Exports: $1.5 million annually
– Carnot Laboratorios has been focusing on expanding its global presence, exporting Saxagliptin generics to various countries.
8. Silanes Laboratories
– Market share: 7%
– Silanes Laboratories has been a key player in the Mexican pharmaceutical market, offering a wide range of generic medications, including Saxagliptin.
9. Genomma Lab Internacional
– Production volume: 7,500 units per month
– Genomma Lab Internacional has been investing in research and development, ensuring the quality and efficacy of its Saxagliptin generics.
10. Rimsa Laboratorio Farmaceutico
– Market share: 5%
– Rimsa Laboratorio Farmaceutico has been a trusted name in the production of generic medications, including Saxagliptin generics.
Insights:
The demand for generic medications like Saxagliptin in Mexico is expected to continue growing in the coming years, driven by factors such as increasing healthcare access and rising chronic disease prevalence. With a focus on affordability and quality, Mexican generic manufacturers are well-positioned to meet this demand and expand their global presence. As the pharmaceutical industry continues to evolve, companies that invest in research and development and prioritize regulatory compliance will likely see the most success in the market. In 2021, the generic drug market is projected to reach over $300 billion globally, presenting significant opportunities for manufacturers in Mexico to capitalize on this growth.
Related Analysis: View Previous Industry Report
